- Novartis commits $1.1B upfront to take Myricx Bio and its next-gen ADC platformNovartis said Monday it will be spending $1.1 billion upfront to buy Myricx Bio, which has an antibody-drug conjugate payload platform that could offer an edge over current approaches. The Swiss…Endpoints · 20d ago↗ source
- Opinion: The smart way to regulate the peptide boom“The FDA should pursue a structured, clinician-guided framework” on popular peptides, writes former surgeon general Jerome Adams.STAT · 20d ago↗ source
- Opinion: Stopping doctors from ordering unnecessary diagnostic tests requires a structural fix“The medical industry has spent enormous effort making more advanced tests but expended little effort learning how to use tests correctly,” writes Daniel Morgan.